Exercise News and Research

Latest Exercise News and Research

European Phase III clinical trial of budesonide MMX completes patient enrollment

Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.

3 Dec 2009

Dementia patients with certain changes in their brain's white matter more likely to be apathetic

Dementia patients with a certain type of changes in their brain's white matter are more likely to be apathetic than those who do not have these changes, reveals a patient study carried out by the Sahlgrenska Academy and Sahlgrenska University Hospital.

3 Dec 2009

Exercise remains one of the most effective interventions for peripheral artery disease

Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.

3 Dec 2009

Sorin Group includes the first patient in its Clepsydra clinical trial

Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient’s breathing and activity levels every day.

2 Dec 2009

Cancer Prevention Research Conference highlights new research on cancer

The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.

2 Dec 2009

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.’s, New Drug Application (NDA) for ZEGERID OTC™ Capsules (omeprazole/sodium bicarbonate) with a dosage strength of 20 mg of omeprazole for over-the-counter (OTC) treatment of frequent heartburn.

2 Dec 2009

New study identifies link between anticipated unhappiness in old age and young men's binge drinking

Young men who believe that happiness declines with age are more likely to engage in risky health behaviors such as binge drinking. Their misguided negative view of the aging process may act as a disincentive to behave 'sensibly' and encourage them to make the most of the present in anticipation of 'miserable' old age.

2 Dec 2009

Bayer Schering Pharma to develop new BiTE antibody for treatment of solid tumors

Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.

1 Dec 2009

Study examines role of low-oxygen exposure in heart failure patients

Distance runners who live at high altitudes with low oxygen levels are known to improve their performance during races in areas that are at sea level. Can heart failure patients, who suffer from fatigue, improve their exercise performance by staying in a tent-like, high-altitude simulator?

1 Dec 2009

Type 1 diabetes youth have abnormal insulin resistance that may increase risk of cardiovascular disease

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), youth with type 1 diabetes have now been found to have abnormal insulin resistance. Having abnormal insulin resistance appears to negatively affect heart, blood vessel and exercise function in this population.

1 Dec 2009

Researchers identify better strategies to control weight in adolescents

Adolescent obesity is a major public health problem that impacts one out of every three children, resulting in 4-5 million overweight youth in the United States.

1 Dec 2009

China Nepstar Chain Drugstore announces third-quarter financial results

China Nepstar Chain Drugstore Ltd. ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2009.

1 Dec 2009

Investigators identify effective weight control strategies for overweight adolescents

Adolescent obesity is a major public health problem that impacts one out of every three children, resulting in 4-5 million overweight youth in the United States. In a study published in the December 2009 issue of the Journal of the American Dietetic Association, researchers evaluated differences in weight control behaviors, including dietary intake and physical activity, comparing overweight adolescents who lost weight and those who did not in order to better understand which strategies could be most effective.

1 Dec 2009

Centene announces new program to educate children on the importance of active and healthy lifestyle

Centene Corporation today announced the creation of a program called Kids' Club, aimed at educating its child members on a variety of health topics. Centene's health plans are reaching out directly to children with newsletters, contests and other innovative events, such as readings with the author of "The Adventures of Thumbs Up Johnnie(TM)."

30 Nov 2009

Prevalence of osteoarthritis continues to rise; OA expenses nearly 100% higher for women than men

Osteoarthritis (OA), a highly prevalent disease, raised aggregate annual medical care expenditures in the U.S. by $185.5 billion according to researchers from Stony Brook University. Insurers footed $149.4 billion of the total medical spend and out-of-pocket (OOP) expenditures were $36.1 billion (2007 dollars). Results of the cost analysis study are published in the December issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.

30 Nov 2009

High levels of physical activity may damage knees and increase risk for osteoarthritis

Middle-aged men and women who engage in high levels of physical activity may be unknowingly causing damage to their knees and increasing their risk for osteoarthritis, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

30 Nov 2009

CCAC congratulates the Ontario government for expanding access to Avastin

The Colorectal Cancer Association of Canada (CCAC) applauds the Ontario Ministry of Health and Long-Term Care's decision today to provide expanded access of Avastin (bevacizumab) to patients with metastatic colorectal cancer.

30 Nov 2009

Ranaz reports its results for the third-quarter ended September 30, 2009

Ranaz Corporation ("Ranaz"), a company specializing in the manufacturing and marketing of protein and dietary supplements, reported its results today for the third quarter ended September 30, 2009.

27 Nov 2009

Cannasat Therapeutics reports net loss of $336,154 for the three months ended September 30, 2009

Cannasat Therapeutics Inc., a clinical stage pharmaceutical company developing products to treat neurological disorders, today announced its results for the nine months ended September 30, 2009. Unless specified otherwise, all amounts are in Canadian dollars.

27 Nov 2009

Advitech announces merger operations with Botaneco Specialty Ingredients

Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that, further to the consolidation of its common shares on a 8-for-1 basis (the "Consolidation"), the TSX Venture Exchange Inc. (the "TSX-V") has approved the release from escrow of the previously announced acquisition of all the issued and outstanding shares of Botaneco Specialty Ingredients Inc.

27 Nov 2009

Exercise News and Research

Latest Exercise News and Research

European Phase III clinical trial of budesonide MMX completes patient enrollment

Dementia patients with certain changes in their brain's white matter more likely to be apathetic

Exercise remains one of the most effective interventions for peripheral artery disease

Sorin Group includes the first patient in its Clepsydra clinical trial

Cancer Prevention Research Conference highlights new research on cancer

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

New study identifies link between anticipated unhappiness in old age and young men's binge drinking

Bayer Schering Pharma to develop new BiTE antibody for treatment of solid tumors

Study examines role of low-oxygen exposure in heart failure patients

Type 1 diabetes youth have abnormal insulin resistance that may increase risk of cardiovascular disease

Researchers identify better strategies to control weight in adolescents

China Nepstar Chain Drugstore announces third-quarter financial results

Investigators identify effective weight control strategies for overweight adolescents

Centene announces new program to educate children on the importance of active and healthy lifestyle

Prevalence of osteoarthritis continues to rise; OA expenses nearly 100% higher for women than men

High levels of physical activity may damage knees and increase risk for osteoarthritis

CCAC congratulates the Ontario government for expanding access to Avastin

Ranaz reports its results for the third-quarter ended September 30, 2009

Cannasat Therapeutics reports net loss of $336,154 for the three months ended September 30, 2009

Advitech announces merger operations with Botaneco Specialty Ingredients

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Exercise News and Research

Latest Exercise News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in